Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | COV |
---|---|---|
02:47 ET | 500 | 1.1 |
03:12 ET | 2500 | 1.15 |
03:56 ET | 4000 | 1.15 |
03:57 ET | 2000 | 1.15 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Covalon Technologies Ltd | 28.8M | -5.8x | --- |
Numinus Wellness Inc | 23.7M | -0.7x | --- |
Medicure Inc | 10.4M | -11.2x | --- |
Ceapro Inc | 20.4M | -7.5x | --- |
Avicanna Inc | 33.2M | -3.5x | --- |
Immunoprecise Antibodies Ltd | 34.7M | -3.2x | --- |
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $28.8M |
---|---|
Revenue (TTM) | $25.1M |
Shares Outstanding | 25.1M |
Covalon Technologies Ltd does not pay a dividend. | |
Beta | 0.54 |
EPS | $-0.20 |
Book Value | $0.76 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | 1.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.